Review Timeline | CrossMark Policy | ClinMed Features
logo
Journal of

Clinical Gastroenterology and TreatmentISSN: 2469-584X

Archive

 Open Access DOI:10.23937/2469-584X/1510078

Splenic Hematoma as a Rare Complication of Endoscopic Retrograde Cholangiopancreatography

Kulvinder S Bajwa, MD, Anirudh K Madabhushi, MBS, Nadim Jafri, MD, Shinil K Shah, DO and Melissa M Felinski, DO

Article Type: Case Report/Clinical Image | First Published: October 29, 2020

Splenic hematoma after endoscopic retrograde cholangiopancreatography (ERCP) is a rarely reported complication. We describe a patient who developed acute blood loss anemia after ERCP and was found to have a splenic hematoma. She recovered successfully with conservative non operative management. We describe the incidence, diagnosis, potential preventive strategies, as well as management of this rare complication. The patient is an 83-year-old woman with congestive heart failure, hypertension, gas...

 Open Access DOI:10.23937/2469-584X/1510077

Role of Small Intestine in Pathophysiology of Obesity and Metabolic Disease and Review of New Endobariatric Procedure Focusing on Small Intestine

Dhruvan Patel, MD, Ricardo Morgenstern, MD, Anisha Daxini and Steven Lichtenstein, DO

Article Type: Review Article | First Published: October 26, 2020

Malabsorptive procedure mimics Roux-n-Y gastric bypass (RYGB) surgery. RYGB exhibits significant hormonal changes after surgery which results in acute and immediate glycemic control via an anti-diabetic weight-independent mechanism, even without significant weight loss after surgery. Therefore, malabsorptive procedure can be considered metabolic procedure because it will help in reducing weight as well as type 2 diabetes mellitus (T2DM). In this review article, we aim to provide an overview on t...

 Open Access DOI:10.23937/2469-584X/1510076

Liver Abscess and Portal Vein Thrombosis Complicating TACE for HCC: Case Study and Literature Review

El Hassani Younes, Janati Idrissi Karim, Haloua Meriem, Alami Badreeddine, Hafidi Youssef, Boubbou Meryem, Maaroufi Mustapha and Alaoui Lamrani Moulay Youssef

Article Type: Case Study | First Published: October 09, 2020

Major complications after TACE for HCC occur approximatively in 2.7 to 5% of patients. The main complications can be vascular: Within the access artery or the hepatic artery, or non-vascular: Post-embolization syndrome (PES), biliary tract injuries, non-target regional or distant (cerebral or pulmonary) embolization, intra- or extrahepatic infection, TACE induced hepatic failure, hepatic rupture and many others. The incidence of liver abscess in literature varies between 0.2% and 2%. It is stati...

Volume 6
Issue 2